Apalutamide (Erleada)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Apalutamide (Erleada), covering 2021-08-16 to 2021-08-16. Get the full timeline:
Most recent: Clinical Trial Update: An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) [Phase 3]